Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Synchronized Rayleigh and Raman scattering for the characterization of single optically trapped extracellular vesicles.

Enciso-Martinez A, van der Pol E, Lenferink ATM, Terstappen LWMM, van Leeuwen TG, Otto C.

Nanomedicine. 2019 Oct 24;24:102109. doi: 10.1016/j.nano.2019.102109. [Epub ahead of print]

2.

Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment.

Nanou A, Zeune LL, Terstappen LWMM.

Cells. 2019 Aug 20;8(8). pii: E937. doi: 10.3390/cells8080937.

3.

Immuno-capture of extracellular vesicles for individual multi-modal characterization using AFM, SEM and Raman spectroscopy.

Beekman P, Enciso-Martinez A, Rho HS, Pujari SP, Lenferink A, Zuilhof H, Terstappen LWMM, Otto C, Le Gac S.

Lab Chip. 2019 Jul 23;19(15):2526-2536. doi: 10.1039/c9lc00081j.

PMID:
31292600
4.

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors.

Tamminga M, de Wit S, Hiltermann TJN, Timens W, Schuuring E, Terstappen LWMM, Groen HJM.

J Immunother Cancer. 2019 Jul 10;7(1):173. doi: 10.1186/s40425-019-0649-2.

5.

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.

Lindsay CR, Blackhall FH, Carmel A, Fernandez-Gutierrez F, Gazzaniga P, Groen HJM, Hiltermann TJN, Krebs MG, Loges S, López-López R, Muinelo-Romay L, Pantel K, Priest L, Riethdorf S, Rossi E, Terstappen L, Wikman H, Soria JC, Farace F, Renehan A, Dive C, Besse B, Michiels S.

Eur J Cancer. 2019 Aug;117:60-68. doi: 10.1016/j.ejca.2019.04.019. Epub 2019 Jun 27.

6.

Multiplex Label Free Characterization of Cancer Cell Lines Using Surface Plasmon Resonance Imaging.

Stojanović I, Ruivo CF, van der Velden TJG, Schasfoort RBM, Terstappen LWMM.

Biosensors (Basel). 2019 May 27;9(2). pii: E70. doi: 10.3390/bios9020070.

7.

Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.

Sumanasuriya S, Omlin A, Armstrong A, Attard G, Chi KN, Bevan CL, Shibakawa A, IJzerman MJ, De Laere B, Lolkema M, Lorente D, Luo J, Mehra N, Olmos D, Scher H, Soule H, Stoecklein NH, Terstappen LWMM, Waugh D, de Bono JS.

Eur Urol Oncol. 2018 Jun;1(2):151-159. doi: 10.1016/j.euo.2018.02.009. Epub 2018 May 15. Review.

8.

A microwell array platform to print and measure biomolecules produced by single cells.

Abali F, Broekmaat J, Tibbe A, Schasfoort RBM, Zeune L, Terstappen LWMM.

Lab Chip. 2019 May 14;19(10):1850-1859. doi: 10.1039/c9lc00100j.

PMID:
31041434
9.

Tumor cell capture from blood by flowing across antibody-coated surfaces.

Andree KC, Mentink A, Nguyen AT, Goldsteen P, van Dalum G, Broekmaat JJ, van Rijn CJM, Terstappen LWMM.

Lab Chip. 2019 Mar 13;19(6):1006-1012. doi: 10.1039/c8lc01158c.

PMID:
30762848
10.

Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.

Berghuis AMS, van Deurzen CHM, Koffijberg H, Terstappen LWMM, Sleijfer S, IJzerman MJ.

Breast Cancer Res Treat. 2019 Jun;175(2):451-458. doi: 10.1007/s10549-019-05141-y. Epub 2019 Feb 13.

11.

Self-Seeding Microwells to Isolate and Assess the Viability of Single Circulating Tumor Cells.

Andree KC, Abali F, Oomens L, Passanha FR, Broekmaat JJ, Kraan J, Mendelaar PAJ, Sleijfer S, Terstappen LWMM.

Int J Mol Sci. 2019 Jan 23;20(3). pii: E477. doi: 10.3390/ijms20030477.

12.

Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent.

Rikkert LG, Nieuwland R, Terstappen LWMM, Coumans FAW.

J Extracell Vesicles. 2019 Jan 9;8(1):1555419. doi: 10.1080/20013078.2018.1555419. eCollection 2019.

13.

CTC Technologies and Tools.

Coumans F, van Dalum G, Terstappen LWMM.

Cytometry A. 2018 Dec;93(12):1197-1201. doi: 10.1002/cyto.a.23684. Epub 2018 Dec 13. No abstract available.

PMID:
30548774
14.

Single tube liquid biopsy for advanced non-small cell lung cancer.

de Wit S, Rossi E, Weber S, Tamminga M, Manicone M, Swennenhuis JF, Groothuis-Oudshoorn CGM, Vidotto R, Facchinetti A, Zeune LL, Schuuring E, Zamarchi R, Hiltermann TJN, Speicher MR, Heitzer E, Terstappen LWMM, Groen HJM.

Int J Cancer. 2019 Jun 15;144(12):3127-3137. doi: 10.1002/ijc.32056. Epub 2019 Jan 28.

PMID:
30536653
15.

EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.

de Wit S, Manicone M, Rossi E, Lampignano R, Yang L, Zill B, Rengel-Puertas A, Ouhlen M, Crespo M, Berghuis AMS, Andree KC, Vidotto R, Trapp EK, Tzschaschel M, Colomba E, Fowler G, Flohr P, Rescigno P, Fontes MS, Zamarchi R, Fehm T, Neubauer H, Rack B, Alunni-Fabbroni M, Farace F, De Bono J, IJzerman MJ, Terstappen LWMM.

Oncotarget. 2018 Nov 2;9(86):35705-35716. doi: 10.18632/oncotarget.26298. eCollection 2018 Nov 2.

16.

Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles.

Nanou A, Crespo M, Flohr P, De Bono JS, Terstappen LWMM.

Cancers (Basel). 2018 Oct 31;10(11). pii: E416. doi: 10.3390/cancers10110416.

17.

Trends in SPR Cytometry: Advances in Label-Free Detection of Cell Parameters.

Schasfoort RBM, Abali F, Stojanovic I, Vidarsson G, Terstappen LWMM.

Biosensors (Basel). 2018 Oct 30;8(4). pii: E102. doi: 10.3390/bios8040102. Review.

18.

Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis.

de Wit S, Zeune LL, Hiltermann TJN, Groen HJM, Dalum GV, Terstappen LWMM.

Cancers (Basel). 2018 Oct 10;10(10). pii: E377. doi: 10.3390/cancers10100377.

19.

How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring.

Zeune LL, de Wit S, Berghuis AMS, IJzerman MJ, Terstappen LWMM, Brune C.

Cytometry A. 2018 Dec;93(12):1202-1206. doi: 10.1002/cyto.a.23576. Epub 2018 Sep 24.

20.

Label-Free Prostate Cancer Detection by Characterization of Extracellular Vesicles Using Raman Spectroscopy.

Lee W, Nanou A, Rikkert L, Coumans FAW, Otto C, Terstappen LWMM, Offerhaus HL.

Anal Chem. 2018 Oct 2;90(19):11290-11296. doi: 10.1021/acs.analchem.8b01831. Epub 2018 Sep 10.

21.

Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis.

Lambros MB, Seed G, Sumanasuriya S, Gil V, Crespo M, Fontes M, Chandler R, Mehra N, Fowler G, Ebbs B, Flohr P, Miranda S, Yuan W, Mackay A, Ferreira A, Pereira R, Bertan C, Figueiredo I, Riisnaes R, Rodrigues DN, Sharp A, Goodall J, Boysen G, Carreira S, Bianchini D, Rescigno P, Zafeiriou Z, Hunt J, Moloney D, Hamilton L, Neves RP, Swennenhuis J, Andree K, Stoecklein NH, Terstappen LWMM, de Bono JS.

Clin Cancer Res. 2018 Nov 15;24(22):5635-5644. doi: 10.1158/1078-0432.CCR-18-0862. Epub 2018 Aug 9.

PMID:
30093450
22.

Health economic impact of liquid biopsies in cancer management.

IJzerman MJ, Berghuis AMS, de Bono JS, Terstappen LWMM.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):593-599. doi: 10.1080/14737167.2018.1505505. Epub 2018 Aug 7.

PMID:
30052095
23.

Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).

Andree KC, Mentink A, Zeune LL, Terstappen LWMM, Stoecklein NH, Neves RP, Driemel C, Lampignano R, Yang L, Neubauer H, Fehm T, Fischer JC, Rossi E, Manicone M, Basso U, Marson P, Zamarchi R, Loriot Y, Lapierre V, Faugeroux V, Oulhen M, Farace F, Fowler G, Sousa Fontes M, Ebbs B, Lambros M, Crespo M, Flohr P, de Bono JS.

Int J Cancer. 2018 Nov 15;143(10):2584-2591. doi: 10.1002/ijc.31752. Epub 2018 Sep 19.

24.

All-printed cell counting chambers with on-chip sample preparation for point-of-care CD4 counting.

Wasserberg D, Zhang X, Breukers C, Connell BJ, Baeten E, van den Blink D, S O L À Benet È, Bloem AC, Nijhuis M, Wensing AMJ, Terstappen LWMM, Beck M.

Biosens Bioelectron. 2018 Oct 15;117:659-668. doi: 10.1016/j.bios.2018.07.002. Epub 2018 Jul 3.

25.

Evidence on the cost of breast cancer drugs is required for rational decision making.

Berghuis AMS, Koffijberg H, Terstappen LWMM, Sleijfer S, IJzerman MJ.

Ecancermedicalscience. 2018 Apr 16;12:825. doi: 10.3332/ecancer.2018.825. eCollection 2018.

26.

Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.

Lorente D, Olmos D, Mateo J, Dolling D, Bianchini D, Seed G, Flohr P, Crespo M, Figueiredo I, Miranda S, Scher HI, Terstappen LWMM, de Bono JS.

Ann Oncol. 2018 Jul 1;29(7):1554-1560. doi: 10.1093/annonc/mdy172.

PMID:
29741566
27.

Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.

Nanou A, Coumans FAW, van Dalum G, Zeune LL, Dolling D, Onstenk W, Crespo M, Fontes MS, Rescigno P, Fowler G, Flohr P, Brune C, Sleijfer S, de Bono JS, Terstappen LWMM.

Oncotarget. 2018 Apr 10;9(27):19283-19293. doi: 10.18632/oncotarget.25019. eCollection 2018 Apr 10.

28.

Parallel probing of drug uptake of single cancer cells on a microfluidic device.

Yang Y, Le Gac S, Terstappen LW, Rho HS.

Electrophoresis. 2018 Feb;39(3):548-556. doi: 10.1002/elps.201700351. Epub 2017 Dec 21.

PMID:
29193175
29.

Quantifying HER-2 expression on circulating tumor cells by ACCEPT.

Zeune L, van Dalum G, Decraene C, Proudhon C, Fehm T, Neubauer H, Rack B, Alunni-Fabbroni M, Terstappen LWMM, van Gils SA, Brune C.

PLoS One. 2017 Oct 30;12(10):e0186562. doi: 10.1371/journal.pone.0186562. eCollection 2017.

30.

Surface Plasmon Resonance is an Analytically Sensitive Method for Antigen Profiling of Extracellular Vesicles.

Gool EL, Stojanovic I, Schasfoort RBM, Sturk A, van Leeuwen TG, Nieuwland R, Terstappen LWMM, Coumans FAW.

Clin Chem. 2017 Oct;63(10):1633-1641. doi: 10.1373/clinchem.2016.271049. Epub 2017 Aug 7.

31.

Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey.

Lorente D, Ravi P, Mehra N, Pezaro C, Omlin A, Gilman A, Miranda M, Rescigno P, Kolinsky M, Porta N, Bianchini D, Tunariu N, Perez R, Mateo J, Payne H, Terstappen L, IJzerman M, Hall E, de Bono J.

Eur Urol Focus. 2018 Mar;4(2):235-244. doi: 10.1016/j.euf.2016.09.005. Epub 2016 Oct 10.

32.

Isolation of single cells for protein therapeutics using microwell selection and Surface Plasmon Resonance imaging.

Abali F, Stevens M, Tibbe AGJ, Terstappen LWMM, van der Velde PN, Schasfoort RBM.

Anal Biochem. 2017 Aug 15;531:45-47. doi: 10.1016/j.ab.2017.05.021. Epub 2017 May 22.

33.

Distinguishing septic from normal donors by detection of sPLA2-IIA from human plasma using a microsieve-based immunoassay.

Zweitzig DR, Tibbe AG, Kopnitsky MJ, Cichonski K, Terstappen LWMM.

J Immunol Methods. 2017 Aug;447:86-91. doi: 10.1016/j.jim.2017.04.007. Epub 2017 Apr 19.

PMID:
28433579
34.

Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility.

Berghuis AMS, Koffijberg H, Prakash J, Terstappen LW, IJzerman MJ.

Int J Mol Sci. 2017 Feb 9;18(2). pii: E363. doi: 10.3390/ijms18020363. Review.

35.

DNA Detection by Flow Cytometry using PNA-Modified Metal-Organic Framework Particles.

Mejia-Ariza R, Rosselli J, Breukers C, Manicardi A, Terstappen LW, Corradini R, Huskens J.

Chemistry. 2017 Mar 23;23(17):4180-4186. doi: 10.1002/chem.201605803. Epub 2017 Feb 28.

36.

Improving the CellSearch® system.

Swennenhuis JF, van Dalum G, Zeune LL, Terstappen LW.

Expert Rev Mol Diagn. 2016 Dec;16(12):1291-1305. Epub 2016 Nov 17.

PMID:
27797592
37.

Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.

Pore M, Meijer C, de Bock GH, Boersma-van Ek W, Terstappen LW, Groen HJ, Timens W, Kruyt FA, Hiltermann TJ.

Clin Lung Cancer. 2016 Nov;17(6):535-542. doi: 10.1016/j.cllc.2016.05.015. Epub 2016 Jun 8.

PMID:
27363902
38.

Temperature-Switch Cytometry-Releasing Antibody on Demand from Inkjet-Printed Gelatin for On-Chip Immunostaining.

Zhang X, Wasserberg D, Breukers C, Terstappen LWMM, Beck M.

ACS Appl Mater Interfaces. 2016 Oct 19;8(41):27539-27545. doi: 10.1021/acsami.6b09206. Epub 2016 Oct 11.

PMID:
27684590
39.

Feasibility of a simple microsieve-based immunoassay platform.

Zweitzig DR, Tibbe AG, Nguyen AT, van Rijn CJ, Kopnitsky MJ, Cichonski K, Terstappen LW.

J Immunol Methods. 2016 Oct;437:21-7. doi: 10.1016/j.jim.2016.07.002. Epub 2016 Jul 21.

PMID:
27448458
40.

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer.

Lorente D, Olmos D, Mateo J, Bianchini D, Seed G, Fleisher M, Danila DC, Flohr P, Crespo M, Figueiredo I, Miranda S, Baeten K, Molina A, Kheoh T, McCormack R, Terstappen LW, Scher HI, de Bono JS.

Eur Urol. 2016 Dec;70(6):985-992. doi: 10.1016/j.eururo.2016.05.023. Epub 2016 Jun 9.

41.

Capture of Tumor Cells on Anti-EpCAM-Functionalized Poly(acrylic acid)-Coated Surfaces.

Andree KC, Barradas AM, Nguyen AT, Mentink A, Stojanovic I, Baggerman J, van Dalum J, van Rijn CJ, Terstappen LW.

ACS Appl Mater Interfaces. 2016 Jun 15;8(23):14349-56. doi: 10.1021/acsami.6b01241. Epub 2016 Jun 1.

PMID:
27187784
42.

Controlled antibody release from gelatin for on-chip sample preparation.

Zhang X, Wasserberg D, Breukers C, Terstappen LW, Beck M.

Analyst. 2016 May 10;141(10):3068-76. doi: 10.1039/c5an02090e.

PMID:
27077142
43.

Modeling single cell antibody excretion on a biosensor.

Stojanović I, Baumgartner W, van der Velden TJ, Terstappen LW, Schasfoort RB.

Anal Biochem. 2016 Jul 1;504:1-3. doi: 10.1016/j.ab.2016.03.018. Epub 2016 Mar 31.

PMID:
27040182
44.

Interpolation method for accurate affinity ranking of arrayed ligand-analyte interactions.

Schasfoort RB, Andree KC, van der Velde N, van der Kooi A, Stojanović I, Terstappen LW.

Anal Biochem. 2016 May 1;500:21-3. doi: 10.1016/j.ab.2016.01.023. Epub 2016 Feb 13.

PMID:
26878776
45.

Challenges in circulating tumor cell detection by the CellSearch system.

Andree KC, van Dalum G, Terstappen LW.

Mol Oncol. 2016 Mar;10(3):395-407. doi: 10.1016/j.molonc.2015.12.002. Epub 2015 Dec 25. Review.

46.

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.

Janni WJ, Rack B, Terstappen LW, Pierga JY, Taran FA, Fehm T, Hall C, de Groot MR, Bidard FC, Friedl TW, Fasching PA, Brucker SY, Pantel K, Lucci A.

Clin Cancer Res. 2016 May 15;22(10):2583-93. doi: 10.1158/1078-0432.CCR-15-1603. Epub 2016 Jan 5.

47.

Programmable v-type valve for cell and particle manipulation in microfluidic devices.

Rho HS, Yang Y, Hanke AT, Ottens M, Terstappen LW, Gardeniers H.

Lab Chip. 2016 Jan 21;16(2):305-11. doi: 10.1039/c5lc01206f.

PMID:
26648416
48.

Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.

Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW.

Expert Rev Mol Diagn. 2016;16(2):147-64. doi: 10.1586/14737159.2016.1123095. Epub 2015 Dec 16. Review.

PMID:
26587751
49.

CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer.

Mehra N, Zafeiriou Z, Lorente D, Terstappen LW, de Bono JS.

Clin Cancer Res. 2015 Nov 15;21(22):4992-5. doi: 10.1158/1078-0432.CCR-14-3129.

50.

Microfluidic device for DNA amplification of single cancer cells isolated from whole blood by self-seeding microwells.

Yang Y, Rho HS, Stevens M, Tibbe AG, Gardeniers H, Terstappen LW.

Lab Chip. 2015 Nov 21;15(22):4331-7. doi: 10.1039/c5lc00816f.

PMID:
26400672

Supplemental Content

Loading ...
Support Center